JP2002508773A5 - - Google Patents

Download PDF

Info

Publication number
JP2002508773A5
JP2002508773A5 JP1999505984A JP50598499A JP2002508773A5 JP 2002508773 A5 JP2002508773 A5 JP 2002508773A5 JP 1999505984 A JP1999505984 A JP 1999505984A JP 50598499 A JP50598499 A JP 50598499A JP 2002508773 A5 JP2002508773 A5 JP 2002508773A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1999505984A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002508773A (ja
Filing date
Publication date
Priority claimed from BE9700572A external-priority patent/BE1011251A3/fr
Application filed filed Critical
Publication of JP2002508773A publication Critical patent/JP2002508773A/ja
Publication of JP2002508773A5 publication Critical patent/JP2002508773A5/ja
Withdrawn legal-status Critical Current

Links

JP50598499A 1997-07-03 1998-07-02 活性物質及びシクロデキストリンを含有する経口投与用医薬剤 Withdrawn JP2002508773A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE9700572 1997-07-03
BE9700572A BE1011251A3 (fr) 1997-07-03 1997-07-03 Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
PCT/BE1998/000100 WO1999001133A1 (fr) 1997-07-03 1998-07-02 Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007004722A Division JP2007091760A (ja) 1997-07-03 2007-01-12 活性物質及びシクロデキストリンを含有する経口投与用医薬剤

Publications (2)

Publication Number Publication Date
JP2002508773A JP2002508773A (ja) 2002-03-19
JP2002508773A5 true JP2002508773A5 (https=) 2006-10-26

Family

ID=3890611

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50598499A Withdrawn JP2002508773A (ja) 1997-07-03 1998-07-02 活性物質及びシクロデキストリンを含有する経口投与用医薬剤
JP2007004722A Pending JP2007091760A (ja) 1997-07-03 2007-01-12 活性物質及びシクロデキストリンを含有する経口投与用医薬剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007004722A Pending JP2007091760A (ja) 1997-07-03 2007-01-12 活性物質及びシクロデキストリンを含有する経口投与用医薬剤

Country Status (20)

Country Link
US (1) US6455533B1 (https=)
EP (1) EP0994710B2 (https=)
JP (2) JP2002508773A (https=)
KR (1) KR100551510B1 (https=)
CN (1) CN1150900C (https=)
AT (1) ATE224717T1 (https=)
AU (1) AU727140B2 (https=)
BE (1) BE1011251A3 (https=)
BR (1) BR9810495A (https=)
CA (1) CA2294783C (https=)
DE (1) DE69808297T3 (https=)
DK (1) DK0994710T4 (https=)
ES (1) ES2184293T5 (https=)
ID (1) ID23806A (https=)
IL (1) IL133397A (https=)
NZ (1) NZ501820A (https=)
PL (1) PL192348B1 (https=)
PT (1) PT994710E (https=)
RU (1) RU2192863C2 (https=)
WO (1) WO1999001133A1 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
BR0206979A (pt) * 2001-02-05 2004-04-20 Scherer Technologies Inc R P Métodos e composições para reduzir o paladar de agentes farmaceuticamente ativos
NZ534039A (en) * 2002-01-15 2006-08-31 Ucb Farchim S Formulations of pharmaceutical compositions for oral administration
ATE388693T1 (de) * 2002-04-04 2008-03-15 Pfizer Prod Inc Wohlschmeckende kautablette
ATE464883T1 (de) * 2004-07-22 2010-05-15 Bend Res Inc Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin
US20060147518A1 (en) * 2004-12-30 2006-07-06 Pierre Fabre Medicament Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
US20070086974A1 (en) * 2005-10-06 2007-04-19 Gawande Rahul S Cetirizine compositions
WO2007144902A1 (en) * 2006-06-12 2007-12-21 Jubliant Organosys Limited Chewable bilayer tablet formulation
JP2008143807A (ja) * 2006-12-07 2008-06-26 Sato Pharmaceutical Co Ltd 感冒薬カプセル剤及びその製造方法
EP2178521B1 (en) * 2007-07-11 2014-01-15 Fertin Pharma A/S Stable medicated chewing gum comprising cyclodextrin inclusion complex
EP2178522A1 (en) * 2007-07-11 2010-04-28 Fertin Pharma A/S Compressed chewing gum tablet comprising taste-masking agent
WO2009054432A1 (ja) * 2007-10-26 2009-04-30 Daiichi Sankyo Company, Limited 口腔内速崩壊性医薬組成物およびその製造方法
US8138192B2 (en) * 2007-10-31 2012-03-20 Genebiology, Inc. Injectable meclizine formulations and methods
EP2067469A1 (en) 2007-11-06 2009-06-10 Teva Pharmaceutical Industries Ltd. Chewable formulations
EP2344137B1 (en) * 2008-09-05 2015-12-02 Johnson & Johnson Consumer Inc. Method for making cetirizine tablets
MY162940A (en) 2009-08-19 2017-07-31 Eisai R&D Man Co Ltd Quinoline derivative-containing pharmaceutical composition
WO2011110939A2 (en) * 2010-03-11 2011-09-15 Rubicon Research Private Limited Pharmaceutical compositions of substituted benzhydrylpiperazines
HK1161509A2 (en) * 2010-06-04 2012-07-27 全球药物科技有限公司 Oral meclizine aqueous formulations with taste flavoring agent
CN101905027A (zh) * 2010-07-27 2010-12-08 北京华禧联合科技发展有限公司 含米格列奈钙和环糊精的口服药用组合物
PH12013500477A1 (en) 2010-09-13 2018-01-17 Bev Rx Inc Aqueous drug delivery system comprising off-flavor masking agent
JP6038128B2 (ja) 2011-06-03 2016-12-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 レンバチニブ化合物に対する甲状腺癌対象及び腎臓癌対象の反応性を予測及び評価するためのバイオマーカー
RU2589833C2 (ru) * 2013-12-12 2016-07-10 Общество С Ограниченной Ответственностью "Фарма Старт" Твердая лекарственная форма препарата седативного и снотворного действия
PL3122330T3 (pl) * 2014-03-27 2019-01-31 Ucb Farchim, S.A. Kompozycje farmaceutyczne zawierające lewocetyryzynę
PT3524595T (pt) 2014-08-28 2022-09-19 Eisai R&D Man Co Ltd Derivado de quinolina altamente puro e método para produção do mesmo
LT3263106T (lt) 2015-02-25 2024-01-10 Eisai R&D Management Co., Ltd. Chinolino darinių kartumo sumažinimo būdas
KR102662228B1 (ko) 2015-03-04 2024-05-02 머크 샤프 앤드 돔 코포레이션 암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
MX373231B (es) 2015-06-16 2020-05-08 Eisai R&D Man Co Ltd Agente anticancerigeno.
US12220398B2 (en) 2015-08-20 2025-02-11 Eisai R&D Management Co., Ltd. Tumor therapeutic agent
US12303505B2 (en) 2017-02-08 2025-05-20 Eisai R&D Management Co., Ltd. Tumor-treating pharmaceutical composition
RU2019134940A (ru) 2017-05-16 2021-06-16 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Лечение гепатоцеллюлярной карциномы
KR102110304B1 (ko) * 2017-06-30 2020-05-14 한미약품 주식회사 레보세티리진 및 몬테루카스트를 포함하는 안정성 및 복약순응도가 향상된 복합 츄어블정 및 그 제조방법
EP4099977A1 (en) * 2020-02-03 2022-12-14 Johnson & Johnson Consumer Inc. A single layer chewable tablet comprising cetirizine
WO2022106923A1 (en) 2020-11-18 2022-05-27 BioPharma Synergies, S. L. Orodispersible powder composition comprising an antihistamine compound

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
JPS58177949A (ja) * 1982-04-12 1983-10-18 Takeda Chem Ind Ltd ランカシジン群抗生物質包接化合物
JPS60204712A (ja) * 1984-03-29 1985-10-16 Ss Pharmaceut Co Ltd 塩酸メクリジンの安定化液状組成物
JPS63243031A (ja) 1987-03-28 1988-10-07 Tokyo Tanabe Co Ltd 胆汁酸の固形製剤
US5206025A (en) * 1989-05-24 1993-04-27 Rhone-Poulenc Sante Porous pharmaceutical form and its preparation
FR2647343B1 (fr) 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
ES2122042T3 (es) 1992-09-24 1998-12-16 Sepracor Inc Tratamiento de rinitis alergica y asma que emplea (-)cetirizina.
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
KR960706490A (ko) * 1993-12-01 1996-12-09 헤르베르트 서키· 헤르베르트 루프 치환된 아미노알킬아미노피리딘(substituted aminoalkylaminopyridines)
US5866179A (en) 1996-05-03 1999-02-02 Avant-Garde Technologies & Products S.A. Medicated chewing gum and a process for preparation thereof
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
ATE464883T1 (de) * 2004-07-22 2010-05-15 Bend Res Inc Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin

Similar Documents

Publication Publication Date Title
JP2000509635A5 (https=)
JP2000509942A5 (https=)
JP2000509912A5 (https=)
JP2000509637A5 (https=)
JP2000510751A5 (https=)
JP2002511841A5 (https=)
JP2000507042A5 (https=)
JP2002514117A5 (https=)
JP2001507518A5 (https=)
JP2000509587A5 (https=)
JP2000507369A5 (https=)
JP2000507433A5 (https=)
JP2001505753A5 (https=)
JP2001511149A5 (https=)
JP2000510793A5 (https=)
JP2002503179A5 (https=)
JP2000508022A5 (https=)
JP2002508773A5 (https=)
JP2000508680A5 (https=)
JP2000509804A5 (https=)
JP2000509853A5 (https=)
JP2000509755A5 (https=)
JP2000510247A5 (https=)
JP2000510969A5 (https=)
JP2000508102A5 (https=)